Puma Biotechnology Inc (PBYI) returns
Puma Biotechnology returns over 10 years
$1,000 invested in Puma Biotechnology ten years ago was worth $265.99 at the close on October 30, 2026, with dividends reinvested: an average return of -12.4% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +5.1% | — | $1,051 | -0.9% |
| 3 months | +32.3% | — | $1,323 | +2.1% |
| Year to date | +75.5% | — | $1,755 | +11.7% |
| 1 year | +91.2% | — | $1,912 | +12.4% |
| 3 years | +315.9% | +60.8% | $4,159 | +88.5% |
| 5 years | +104.7% | +15.4% | $2,047 | +76.0% |
| 10 years | -73.4% | -12.4% | $265.99 | +316.6% |
Puma Biotechnology return by calendar year
| Year | PBYI | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +75.5% | +11.7% | +63.8% |
| 2025 | +95.1% | +17.7% | +77.4% |
| 2024 | -29.6% | +24.9% | -54.4% |
| 2023 | +2.4% | +26.2% | -23.8% |
| 2022 | +39.1% | -18.2% | +57.3% |
| 2021 | -70.4% | +28.7% | -99.1% |
| 2020 | +17.3% | +18.4% | -1.1% |
| 2019 | -57.0% | +31.2% | -88.2% |
| 2018 | -79.4% | -4.6% | -74.9% |
| 2017 | +222.0% | +21.7% | +200.3% |
| 2016 | -60.8% | +12.0% | -72.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: PBYI financials · PBYI valuation
No forecast, no recommendation. This page describes Puma Biotechnology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.